SECsense Logo

Johnson & Johnson 8-K Report: Key Financial Insights & Obligations as of Feb 2025

$JNJ
Form 8-K
Filed on: 2025-02-20
Source
Johnson & Johnson 8-K Report: Key Financial Insights & Obligations as of Feb 2025

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Identification:
  • The report pertains to Johnson & Johnson (CIK: 0000200406).
  1. Filing Type:
  • The document is identified as an 8-K filing, which is typically used to report significant events that shareholders should know about.
  1. Filing Date:
  • The report is dated February 20, 2025.
  1. Segment Information:
  • The report includes various segments of stock and notes due:
    • Common Stock (Par Value $1.00).
    • Specific notes with maturity dates and interest rates:
    • 1.150% Notes Due November 2028 (JNJ28)
    • 3.200% Notes Due June 2032 (JNJ32)
    • 1.650% Notes Due May 2035 (JNJ35)
    • 3.350% Notes Due June 2036 (JNJ36A)
    • 3.550% Notes Due June 2044 (JNJ44)
  1. Exchange Listings:
  • The securities are listed on the New York Stock Exchange (NYSE).
  1. Location:
  • The corporate headquarters is located at One Johnson & Johnson Plaza, New Brunswick, NJ 08933.
  1. Contact Information:
  • The contact number provided is 732-524-0400.
  1. Regulatory Compliance:
  • The document adheres to US GAAP standards, indicating robust regulatory compliance.

The above information highlights key aspects of Johnson & Johnson's financial standing and obligations as of the reporting date, including their common stock and various notes with specified interest rates and maturity dates. This data can be critical for investors and analysts assessing the company's financial health and investment opportunities.